Objective:

Primary open-angle glaucoma (POAG) is a degenerative optic neuropathy disease which has somewhat similar pathophysiology to Alzheimer’s disease (AD). This study aims to determine the presence of medial temporal atrophy and parietal lobe atrophy in patients with POAG compared to normal controls using medial temporal atrophy (MTA) scoring and posterior cortical atrophy (PCA) scoring system on T1 magnetization-prepared rapid gradient-echo.

Methods:

50 POAG patients and 50 normal subjects were recruited and an MRI brain with T1-magnetization-prepared rapid gradient-echo was performed. Medial temporal lobe and parietal lobe atrophy were by MTA and PCA/Koedam scoring. The score of the PCA and MTA were compared between the POAG group and the controls.

Results:

There was a significant statistical difference between PCA score in POAG and the healthy control group (p-value = 0.026). There is no statistical difference between MTA score in POAG compared to the healthy control group (p-value = 0.58).

Conclusion:

This study suggests a correlation between POAG and PCA score. Potential application of this scoring method in clinical diagnosis and monitoring of POAG patients.

Advances in knowledge:

The scoring method used in AD may also be applied in the diagnosis and monitoring of POAG

MRI brain, specifically rapid volumetric T1 spoiled gradient echo sequence, may be applied in POAG assessment.

1. Allingham, R. R., Damji, K. F., Freedman, S. F., Moroi, S. E., Rhee, D. J., & Shields, M. B. (2012). Shields' textbook of glaucoma. Lippincott Williams & Wilkins.
2. Wostyn, P., Audenaert, K., & De Deyn, P. P. (2008). Alzheimer’s disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure. Clinical Neurology and Neurosurgery, 110(1), 101–109. https://doi.org/10.1016/j.clineuro.2007.10.011
3. Fechtner, R. D., & Weinreb, R. N. (1994). Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol, 39(1), 23–42. https://doi.org/10.1016/s0039-6257(05)80042-6
4. Heijl, A., Leske, M. C., Bengtsson, B., Hyman, L., Bengtsson, B., & Early Manifest Glaucoma Trial Group. (2002). Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Archives of Ophthalmology, 120(10), 1268–1279. https://doi.org/10.1001/archopht.120.10.1268
5. Klein, B. E., Klein, R., Sponsel, W. E., Franke, T., Cantor, L. B., Martone, J., & Menage, M. J. (1992). Prevalence of glaucoma: The Beaver Dam Eye Study. Ophthalmology, 99(10), 1499–1504. https://doi.org/10.1016/s0161-6420(92)31774-9
6. Guo, L., Duggan, J., & Cordeiro, M. F. (2010). Alzheimer’s disease and retinal neurodegeneration. Current Alzheimer Research, 7(1), 3–14. https://doi.org/10.2174/156720510790274491
7. Guo, L., Salt, T. E., Luong, V., Wood, N., Cheung, W., Maass, A., Bizrah, M., & Cordeiro, M. F. (2007). Targeting amyloid-beta in glaucoma treatment. Proceedings of the National Academy of Sciences, 104(33), 13444–13449. https://doi.org/10.1073/pnas.0703707104
8. Kountouras, J., Zavos, C., Gavalas, E., Boziki, M., Chatzopoulos, D., & Venizelos, I. (2007). Normal-tension glaucoma and Alzheimer’s disease: Helicobacter pylori as a possible common underlying risk factor. Medical Hypotheses, 68(1), 228–229. https://doi.org/10.1016/j.mehy.2006.07.008
9. Parisi, V. (2003). Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease. Seminars in Ophthalmology, 18(2), 50–57. https://doi.org/10.1080/08820530390897855
10. Wostyn, P., Audenaert, K., & De Deyn, P. P. (2009). Alzheimer’s disease and glaucoma: Is there a causal relationship? British Journal of Ophthalmology, 93(12), 1557–1559. https://doi.org/10.1136/bjo.2008.148064
11. Bayer, A. U., Ferrari, F., & Erb, C. (2002). High occurrence rate of glaucoma among patients with Alzheimer’s disease. European Neurology, 47(3), 165–168. https://doi.org/10.1159/000047976
12. Tamura, H., Kawakami, H., Kanamoto, T., Kato, T., Yokoyama, T., Sasaki, K., & Kohriyama, T. (2006). High frequency of open-angle glaucoma in Japanese patients with Alzheimer’s disease. Journal of the Neurological Sciences, 246(1-2), 79–83. https://doi.org/10.1016/j.jns.2006.02.009
13. McKinnon, S. J. (2003). Glaucoma: Ocular Alzheimer’s disease? Frontiers in Bioscience, 8, s1140–s1156. https://doi.org/10.2741/1172
14. Wostyn, P., Audenaert, K., & De Deyn, P. P. (2010). Alzheimer’s disease: Cerebral glaucoma? Medical Hypotheses, 74(6), 973–977. https://doi.org/10.1016/j.mehy.2009.12.019
15. Kashiwagi, K., Okubo, T., & Tsukahara, S. (2004). Association of magnetic resonance imaging of anterior optic pathway with glaucomatous visual field damage and optic disc cupping. Journal of Glaucoma, 13(3), 189–195. https://doi.org/10.1097/00061198-200406000-00003
16. Chen, J., Bushman, F. D., Lewis, J. D., Wu, G. D., & Li, H. (2013). Structure-constrained sparse canonical correlation analysis with an application to microbiome data analysis. Biostatistics, 14(2), 244–258. https://doi.org/10.1093/biostatistics/kxs038
17. Boles Carenini, B., Tettoni, E., & Brogliatti, B. (2002). CT and A echography of optic nerve in glaucoma. Acta Ophthalmologica Scandinavica, 80(S236), 40–41. https://doi.org/10.1034/j.1600-0420.80.s236.23.x
18. Dichtl, A., & Jonas, J. B. (1996). Echographic measurement of optic nerve thickness correlated with neuroretinal rim area and visual field defect in glaucoma. American Journal of Ophthalmology, 122(4), 514–519. https://doi.org/10.1016/s0002-9394(14)72111-7
19. Beatty, S., Good, P. A., McLaughlin, J., & O’Neill, E. C. (1998). Echographic measurements of the retrobulbar optic nerve in normal and glaucomatous eyes. British Journal of Ophthalmology, 82(1), 43–47. https://doi.org/10.1136/bjo.82.1.43
20. Scheltens, P., Leys, D., Barkhof, F., Huglo, D., Weinstein, H. C., Vermersch, P., Kuiper, M., de Brandhof, M., Valk, J., & van der Lugt, P. J. (1992). Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates. Journal of Neurology, Neurosurgery & Psychiatry, 55(10), 967–972. https://doi.org/10.1136/jnnp.55.10.967
21. Burton, E. J., Barber, R., Mukaetova-Ladinska, E. B., Robson, J., Perry, R. H., Jaros, E., Kalaria, R. N., & O'Brien, J. T. (2009). Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis. Brain, 132(1), 195–203. https://doi.org/10.1093/brain/awn298
22. Visser, P. J., Verhey, F. R. J., Hofman, P. A. M., Scheltens, P., & Jolles, J. (2002). Medial temporal lobe atrophy predicts Alzheimer’s disease in patients with minor cognitive impairment. Journal of Neurology, Neurosurgery & Psychiatry, 72(4), 491–497. https://doi.org/10.1136/jnnp.72.4.491
23. Wahlund, L. O. (1996). Magnetic resonance imaging and computed tomography in Alzheimer’s disease. Acta Neurologica Scandinavica, 94(S168), 50–53. https://doi.org/10.1111/j.1600-0404.1996.tb00373.x
24. Wahlund, L. O., Julin, P., Lindqvist, J., & Scheltens, P. (1999). Visual assessment of medical temporal lobe atrophy in demented and healthy control subjects: Correlation with volumetry. Psychiatry Research: Neuroimaging, 90(3), 193–199. https://doi.org/10.1016/s0925-4927(99)00016-5
25. Frisoni, G. B., Testa, C., Sabattoli, F., Beltramello, A., Soininen, H., & Laakso, M. P. (2005). Structural correlates of early and late onset Alzheimer’s disease: Voxel based morphometric study. Journal of Neurology, Neurosurgery & Psychiatry, 76(1), 112–114. https://doi.org/10.1136/jnnp.2003.029876
26. Galton, C. J., Patterson, K., Xuereb, J. H., & Hodges, J. R. (2000). Atypical and typical presentations of Alzheimer’s disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain, 123(3), 484–498. https://doi.org/10.1093/brain/123.3.484
27. Koedam, E. L. G. E., Lehmann, M., van der Flier, W. M., Scheltens, P., Pijnenburg, Y. A. L., Fox, N. C., Barkhof, F., & Wattjes, M. P. (2011). Visual assessment of posterior atrophy development of a MRI rating scale. European Radiology, 21(12), 2618–2625. https://doi.org/10.1007/s00330-011-2205-4
28. McKee, A. C., Au, R., Cabral, H. J., Kowall, N. W., Seshadri, S., Kubilus, C. A., Scammell, K. S., Wolf, P. A., & Frosch, M. P. (2006). Visual association pathology in preclinical Alzheimer disease. Journal of Neuropathology & Experimental Neurology, 65(6), 621–630. https://doi.org/10.1097/00005072-200606000-00010
29. Jacobs, H. I. L., Van Boxtel, M. P. J., Jolles, J., Verhey, F. R. J., & Uylings, H. B. M. (2012). Parietal cortex matters in Alzheimer’s disease: An overview of structural, functional and metabolic findings. Neuroscience & Biobehavioral Reviews, 36(1), 297–309. https://doi.org/10.1016/j.neubiorev.2011.06.009
30. Wang, J., Li, T., Sabel, B. A., Chen, Z., Wen, H., Li, J., Xie, X., Wang, D., & Wang, N. (2016). Structural brain alterations in primary open angle glaucoma: A 3T MRI study. Scientific Reports, 6(1), Article 18969. https://doi.org/10.1038/srep18969
31. Barkhof, F., Polvikoski, T. M., van Straaten, E. C. W., Kalaria, R. N., Sulkava, R., Aronen, H. J., Niinistö, L., Erkinjuntti, T., Scheltens, P., & Ince, P. G. (2007). The significance of medial temporal lobe atrophy: A postmortem MRI study in the very old. Neurology, 69(15), 1521–1527. https://doi.org/10.1212/01.wnl.0000277459.83543.99
32. Kirby, E., Bandelow, S., & Hogervorst, E. (2010). Visual impairment in Alzheimer’s disease: A critical review. Journal of Alzheimer's Disease, 21(1), 15–34. https://doi.org/10.3233/JAD-2010-080785
33. Zikou, A. K., Kitsos, G., Tzarouchi, L. C., Astrakas, L., Alexiou, G. A., Argyropoulou, M. I., & Katsanos, A. (2012). Voxel-based morphometry and diffusion tensor imaging of the optic pathway in primary open-angle glaucoma: A preliminary study. American Journal of Neuroradiology, 33(1), 128–134. https://doi.org/10.3174/ajnr.A2714
34. Ou, Y., Grossman, D. L., Lee, P. P., & Sloan, F. A. (2012). Glaucoma, Alzheimer disease and other dementia: A longitudinal analysis. Ophthalmic Epidemiology, 19(5), 285–292. https://doi.org/10.3109/09286586.2011.649228
35. Kessing, L. V., Lopez, A. G., Andersen, P. K., & Kessing, S. V. (2007). No increased risk of developing Alzheimer disease in patients with glaucoma. Journal of Glaucoma, 16(1), 47–51. https://doi.org/10.1097/IJG.0b013e31802b3527
36. Keenan, T. D. L., Goldacre, R., & Goldacre, M. J. (2015). Associations between primary open angle glaucoma, Alzheimer’s disease and vascular dementia: Record linkage study. British Journal of Ophthalmology, 99(4), 524–527. https://doi.org/10.1136/bjophthalmol-2014-305863
37. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/10.1016/0022-3956(75)90026-6
38. Mitchell, A. J. (2009). A meta-analysis of the accuracy of the Mini-Mental State Examination in the detection of dementia and mild cognitive impairment. Journal of Psychiatric Research, 43(4), 411–431. https://doi.org/10.1016/j.jpsychires.2008.04.014
39. Isaacs, B., & Kennie, A. T. (1973). The Set Test as an aid to the detection of dementia in old people. British Journal of Psychiatry, 123(4), 467–470. https://doi.org/10.1192/bjp.123.4.467
40. Garaci, F. G., Bolacchi, F., Cerulli, A., Melis, M., Spanò, A., Cedrone, C., Hermier, M., Floris, R., Simonetti, G., & Nucci, C. (2009). Optic nerve and optic radiation neurodegeneration in patients with glaucoma: In vivo analysis with 3-T diffusion-tensor MR imaging. Radiology, 252(2), 496–501. https://doi.org/10.1148/radiol.2522081240
41. Hui, E. S., & Fu, Q. L. (2007). Diffusion tensor MR study of optic nerve degeneration in glaucoma. In 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (pp. 4613–4615). IEEE. https://doi.org/10.1109/IEMBS.2007.4353367